This is not the most recent version of the article. View current version (7 OCT 2009)

Intervention Protocol

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema

  1. Mariacristina Parravano1,*,
  2. Francesca Menchini2

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 8 JUL 2009

DOI: 10.1002/14651858.CD007419

Database Title

Additional Information

How to Cite

Parravano M, Menchini F. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD007419. DOI: 10.1002/14651858.CD007419.

Author Information

  1. 1

    Fondazione G.B. Bietti per lo studio e la ricerca in Oftalmolologia-IRCCS, Ophthalmology, Rome, Italy

  2. 2

    University of Udine, Azienda Ospedaliero-universitaria di Udine, Department of Ophthalmology, Udine, Italy

*Mariacristina Parravano, Ophthalmology, Fondazione G.B. Bietti per lo studio e la ricerca in Oftalmolologia-IRCCS, Via Livenza n 3, Rome, 00198, Italy. criparra@tin.it.

Publication History

  1. Publication Status: Unchanged
  2. Published Online: 8 JUL 2009

SEARCH

ARTICLE TOOLS

This is not the most recent version of the article.View current version (07 Oct 2009)

View Full Article (HTML) Full (149K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The aim of this review is to investigate the effects and acceptability of antiangiogenic therapy with anti-VEGF modalities for the treatment of DMO.

View Full Article (HTML) Full (149K)